FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Nov 13, 2018
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on November 13, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Barbara T. Carmichael (FDA Associated Person)
- Julie D. Bringger (FDA Associated Person)
- Valerie J. Grecek-Trinh (Issuing Officer)
View Company Profile
ID · cece048d-42be-4865-95d2-54985f6280fc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1071532
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 630.10(g)(1)Proof Of Identity
- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.20(b)Qualifications of responsible personnel
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 17, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 2, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 3, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 6, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1001534 - 2016-11-17
- FDA Inspection 935254 - 2015-07-02
- FDA Inspection 886548 - 2014-07-03
- FDA Inspection 797851 - 2012-09-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.